Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial to Study the Tolerability and the Effectiveness of Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase With Age More Than 70, Diagnosis of CML is Being Performed Within 1 Year

NCT00219752 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT00219752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00219752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial to Study the Tolerability and the Effectiveness of Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase With Age More Than 70, Diagnosis of CML is Being Performed Within 1 Year
Lead sponsor
Poitiers University Hospital
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2002
Completion date
May 31, 2007
Enrollment
30
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia